Sissel Rodahl
Corporate Officer/Principal bei GENSIGHT BIOLOGICS S.A.
Ursprung des Netzwerks ersten Grades von Sissel Rodahl
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
13
| Extinct | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sissel Rodahl
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Sales & Marketing | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
| FTI CONSULTING, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
| HOSPIRA, INC. | Pharmaceuticals: Major | General Counsel | |
| IPSEN | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| NOVARTIS AG | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Graduate Degree | |
| Iona College | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Iowa | College/University | Undergraduate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chief Operating Officer | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director of Finance/CFO | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
Nations Roof LLC
 Nations Roof LLC Engineering & ConstructionIndustrial Services Nations Roof LLC is a commercial roofing company that specializes in extending the life of commercial roofs. The company is based in Mobile, AL and has subsidiaries in the United States. The company offers services such as full roof replacement, repairs, and maintenance programs. The company was founded in 2004 by Richard M. Nugent, who has been the CEO since 2004. | Engineering & Construction | President | |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Boston Consulting Group SAS
 Boston Consulting Group SAS Miscellaneous Commercial ServicesCommercial Services Boston Consulting Group SAS operates as a management consulting firm. It provides business and other consultancy services. The company is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Pharmaceuticals: Major | Sales & Marketing | |
Inova Software SA
 Inova Software SA Packaged SoftwareTechnology Services Inova Software SA develops management software solutions for biopharmaceutical companies. It offers search & evaluation, opportunities tracking, alliance management, mobile access, reporting and security & performance management software solutions. The company was founded by Gilles Toulemonde, Fritz Eisenhart, and David Carteret in 2010 and is headquartered in Villeurbanne, France. | Packaged Software | Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| Ecole Supérieure de Gestion et Finances | College/University | Graduate Degree | |
| Neu-Ulm University of Applied Sciences | College/University | Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| The University of Michigan Law School | College/University | Graduate Degree | |
| Columbia College (New York) | College/University | Undergraduate Degree | |
| Yale Graduate School of Arts & Sciences | College/University | Graduate Degree | |
| NEOMA Business School | College/University | Graduate Degree | |
Wolf-Medizintechnik GmbH
 Wolf-Medizintechnik GmbH Medical DistributorsDistribution Services Wolf-Medizintechnik GmbH provides services in the fields of x-ray technology and electro medicine. It develops and manufactures systems for superficial and orthovoltage x-ray therapy and special systems used in medicine and non-destructive testing. It also distributes diagnostic x-ray equipment and provides technical and maintenance services. The company was founded in 1990 and is headquartered in St. Gangloff, Germany. | Medical Distributors | Director/Board Member | |
Bluestone Venture Partners LLC
 Bluestone Venture Partners LLC Investment ManagersFinance BlueStone Venture Partners LLC (BlueStone Venture Partners) is a venture capital firm founded in 2017 by Mara G. Aspinall and Tom Nickoloff. The firm is headquartered in Tucson, Arizona. | Investment Managers | Consultant / Advisor | |
| IQVIA | Corporate Officer/Principal | ||
| X4 PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
METAFORA Biosystems SAS
 METAFORA Biosystems SAS BiotechnologyHealth Technology METAFORA Biosystems SAS is a French company that has received a €3.2 million grant from the European Commission's H2020 SME Instrument program. The company is based in Paris, France. The grant will allow the company to launch a large-scale prospective validation study of the METAglut1 test, which helps in the early diagnosis of De Vivo disease, a rare and under-diagnosed disease. The company has also received exceptional reimbursement for the METAglut1 test. The CEO of the company is Romain Kaspereit. | Biotechnology | Director/Board Member | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Universite Paris Cite | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Satellite Biosciences, Inc.
 Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
| AADI BIOSCIENCE, INC. | Biotechnology | Chief Executive Officer | |
| Bio-Up | Chief Executive Officer | ||
AviadoBio Ltd.
 AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
Priothera SAS
 Priothera SAS BiotechnologyHealth Technology Part of Priothera Ltd., Priothera SAS is a French company dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy. The company is based in Saint-Louis, France. Priothera is leading the way in developing Mocravimod, a S1P receptor modulator as an adjunctive and maintenance immune therapy to allo-HSCT and to CAR-T. Mocravimod has the potential to reduce the occurrence of (acute) GVHD without suppressing T cell function, thus GVL is maintained. Priothera is developing Mocravimod (KRP203) to significantly improve the clinical outcome of allo-HSCT and CAR-T therapy. The company was founded in 2020 by Philippe Lievre, Florent Gros, Brice R. Suire, Stephan Oehen, Simone Seiter. Florent Gros has been the CEO since 2020. | Biotechnology | Founder | |
| Threefrog Therapeutics | Chairman | ||
Laverock Therapeutics Ltd.
 Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Pharmaceuticals: Other | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 26 |
| Frankreich | 15 |
| Deutschland | 5 |
| Vereinigtes Königreich | 4 |
| Schweiz | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 18 |
| Finance | 4 |
| Commercial Services | 3 |
| Industrial Services | 2 |
Operativ
| Director/Board Member | 65 |
| Corporate Officer/Principal | 46 |
| Chairman | 24 |
| Undergraduate Degree | 21 |
| Independent Dir/Board Member | 21 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Bernard Gilly | 32 |
| Michael Wyzga | 31 |
| Cédric Moreau | 14 |
| Maritza McIntyre | 14 |
| Elsy Boglioli Hofman | 14 |
| Peter Goodfellow | 13 |
| Rick Modi | 9 |
| Philippe Motté | 8 |
| David Lennon | 8 |
| Dannielle Appelhans | 7 |
| Angela Thedinga | 7 |
| Kamran Alam | 7 |
| Petra Kaufmann | 6 |
| Leigh Shaw | 6 |
| Lisa Deschamps | 6 |
- Börse
- Insiders
- Sissel Rodahl
- Unternehmensverbindungen